Sacituzumab tirumotecan versus treatment of physician's choice in previously treated endometrial cancer (TroFuse-005/ENGOT-en23/GOG-3095): a randomised, open-label, phase 3 trial. (linkinghub.elsevier.com)

Authors: Lorusso D … Pothuri B Journal: The Lancet Published: 2026-10-26 DOI: https://doi.org/10.1016/S0140-6736(26)02099-4